Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
Thanks for that. Perhaps the failure of sarilumab does not represent a class effect of IL-6 inhibitors; the promising benefit of tocilizumab may indicate that some IL-6 targeting drugs are efficacious. So more data and repitition will be needed to sort out whether targeting the cytokine storm with anti-inflammatory IL-6 therapires, or other therapies like apabetalone, have promise.
